Sponsor Pipeline

CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07201688 Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended… Acute Ischemic Stroke Recruiting
Not specified
NCT07519889 Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®)… Acute Ischemic Stroke Not Yet Recruiting
Disease Areas
Stroke (2)
Get alerts when CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free